Shanghai, China

Guoping Hu

This inventor holds 36 USPTO granted patents and 10 published patent applications and 20 EPO patents, primarily in Pharmaceutical Compounds. Top assignees: Medshine Discovery Inc., Chia Tai Tianqing Pharmaceutical Group Co., Ltd., Zhuhai United Laboratories Co., Ltd.. Active years: 2018-2026.

USPTO Granted Patents = 36 

% Patents Active = 80.6

 

Average Co-Inventor Count = 8.1

ph-index = 3

Forward Citations = 26(Granted Patents)


Location History:

  • Nanjing, CN (2019)
  • Wuhan, CN (2020)
  • Dongguan, CN (2020)
  • Shanghai, CN (2018 - 2024)

Company Filing History:

goldMedal12 out of 71 
 
Medshine Discovery Inc.
 patents
silverMedal6 out of 121 
 
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
 patents
bronzeMedal5 out of 8 
 
Zhuhai United Laboratories Co., Ltd.
 patents
4. 1 out of 2 
 
Changzhou Yinsheng Pharmaceutical Co., Ltd.
 patents
5. 1 out of 2 
 
Cisen Pharmaceutical Co., Ltd
 patents
6. 1 out of 32 
 
Cspc Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd.
 patents
7. 1 out of 3 
 
Fujian Cosunter Pharmaceutical Co., Ltd.
 patents
8. 1 out of 7 
 
Genfleet Therapeutics (Shanghai) Inc.
 patents
9. 1 out of 13 
 
Guangdong Raynovent Biotech Co., Ltd.
 patents
10. 1 out of 4 
 
Guangzhou Joyo Pharmatech Co., Ltd.
 patents
11. 1 out of 4 
 
Harbin Zhenbao Pharmaceutical Co., Ltd.
 patents
12. 1 out of 5 
 
Hubei Bio-Pharmaceutical Industrial Technological Institute Inc.
 patents
13. 1 out of 2 
 
Jumbo Drug Bank Co., Ltd.
 patents
14. 1 out of 5 
 
Luoxin Pharmaceutical (Shanghai) Co., Ltd.
 patents
15. 1 out of 2 
 
Phaeno Therapeutics Co., Ltd.
 patents
16. 1 out of 6 
 
Shandong Luoxin Pharmaceutical Group Stock Co., Ltd.
 patents
17. 1 out of 5 
 
Shijiazhuang Sagacity New Drug Development Company, Ltd.
 patents
18. 1 out of 260 
 
Sichuan University
 patents
19. 1 out of 4 
 
Wuxi Fortune Pharmaceutical Co., Ltd
 patents
20. 1 out of 3 
 
Zhejiang Yangli Pharmaceutical Technology Co., Ltd.
 patents
21. 1 out of 2 
 
Zhejiang Yangli Pharmaceutical Technology Co., Ltd.
 patents
22. 1 out of 1 
 
Zhuhai United Laboratories Co., Ltd.
 patent
23. 1 out of 834,307 
Other
 patents
where one patent can have more than one assignee

Years Active: 2018-2026

Loading Chart...
Loading Chart...
Areas of Expertise:
Aminopyridine Compound
Pyrimidine Ring Compound
Estrogen Receptor Antagonist
JAK Inhibitor
FGFR Inhibitor
Retinal Disease Treatment
Pyridone Compound
Pyrrolopyrimidine Compound
Tyrosine Kinase Inhibitor
SMAC Mimetics
PDE4 Inhibitor
Hepatitis C Virus Inhibitors
36 patents (USPTO):Explore Patents

Title: Guoping Hu: Pioneering Innovations in Pharmaceuticals

Introduction:

Guoping Hu, a visionary inventor hailing from Shanghai, China, has made significant contributions to the field of pharmaceuticals. With an impressive portfolio of 27 patents, his groundbreaking work has been at the forefront of advancements in the treatment of various diseases.

Latest Patents:

1. Compound for use in retinal diseases: Guoping's innovative compound, designed as an aldehyde binder, shows promise in the treatment of retinal diseases. This patent represents a significant step forward in addressing ocular health.

2. [1,2,4]triazolo[1,5-a]pyridine compound as JAK inhibitor: Another notable patent by Guoping Hu involves a JAK inhibitor compound, crucial for developing drugs to target diseases associated with JAK1 or TYK2. This patent underscores his commitment to advancing therapies for challenging conditions.

Career Highlights:

Guoping Hu has left an indelible mark on the pharmaceutical industry, with stints at renowned companies such as Medshine Discovery Inc. and Chia Tai Tianqing Pharmaceutical Group Co., Ltd. His expertise and dedication have propelled these organizations towards excellence in drug discovery and development.

Collaborations:

Throughout his illustrious career, Guoping has had the privilege of collaborating with esteemed professionals in the field. Noteworthy among his coworkers are Jian Li and Shuhui Chen, whose collective efforts have led to groundbreaking innovations in the pharmaceutical sector.

Conclusion:

In conclusion, Guoping Hu's inventive spirit and tireless pursuit of excellence have solidified his position as a trailblazer in pharmaceutical research. His patents and collaborations stand as testaments to his unwavering commitment to advancing healthcare solutions, particularly in the realm of cutting-edge drug development for challenging diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…